134 related articles for article (PubMed ID: 37753716)
1. A case-control study addressing the population of epidermal and dermal inflammatory infiltrate including neural milieu in primary prurigo nodularis using S-100 and toluidine blue stain and its therapeutic implications.
Agrawal D; Sardana K; Mathachan SR; Bhardwaj M; Ahuja A; Jain S; Panesar S
Int J Dermatol; 2023 Nov; 62(11):1352-1358. PubMed ID: 37753716
[TBL] [Abstract][Full Text] [Related]
2. Prurigo nodularis: new insights into pathogenesis and novel therapeutics.
Liao V; Cornman HL; Ma E; Kwatra SG
Br J Dermatol; 2024 May; 190(6):798-810. PubMed ID: 38345154
[TBL] [Abstract][Full Text] [Related]
3. Prurigo nodularis: systematic analysis of 58 histological criteria in 136 patients.
Weigelt N; Metze D; Ständer S
J Cutan Pathol; 2010 May; 37(5):578-86. PubMed ID: 20002240
[TBL] [Abstract][Full Text] [Related]
4. A prospective study examining the expression of STAT 1, 3, 6 in prurigo nodularis lesions with its immunopathogenic and therapeutic implications.
Agrawal D; Sardana K; Mathachan SR; Bhardwaj M; Ahuja A; Jain S
J Cosmet Dermatol; 2022 Sep; 21(9):4009-4015. PubMed ID: 34965028
[TBL] [Abstract][Full Text] [Related]
5. Itch intensity in prurigo nodularis is closely related to dermal interleukin-31, oncostatin M, IL-31 receptor alpha and oncostatin M receptor beta.
Hashimoto T; Nattkemper LA; Kim HS; Kursewicz CD; Fowler E; Shah SM; Nanda S; Fayne RA; Paolini JF; Romanelli P; Yosipovitch G
Exp Dermatol; 2021 Jun; 30(6):804-810. PubMed ID: 33428793
[TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of prurigo nodularis].
Raap U; Günther C
Hautarzt; 2014 Aug; 65(8):691-6. PubMed ID: 25113327
[TBL] [Abstract][Full Text] [Related]
7. Prurigo Nodularis: Pathogenesis and the Horizon of Potential Therapeutics.
Yook HJ; Lee JH
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791201
[TBL] [Abstract][Full Text] [Related]
8. Demonstration by S-100 protein staining of increased numbers of nerves in the papillary dermis of patients with prurigo nodularis.
Harris B; Harris K; Penneys NS
J Am Acad Dermatol; 1992 Jan; 26(1):56-8. PubMed ID: 1732336
[TBL] [Abstract][Full Text] [Related]
9. Mast cells, neutrophils, and eosinophils in prurigo nodularis.
Perez GL; Peters MS; Reda AM; Butterfield JH; Peterson EA; Leiferman KM
Arch Dermatol; 1993 Jul; 129(7):861-5. PubMed ID: 8323307
[TBL] [Abstract][Full Text] [Related]
10. Increased IL-31 expression in serum and tissue protein in prurigo nodularis.
Chaowattanapanit S; Wongjirattikarn R; Chaisuriya N; Ungarreevittaya P; Poosekeaw P; Winaikosol K; Choonhakarn C; Julanon N; Salao K
Ther Adv Chronic Dis; 2022; 13():20406223221112561. PubMed ID: 35875833
[TBL] [Abstract][Full Text] [Related]
11. Histamine-containing mast cells and their relationship to NGFr-immunoreactive nerves in prurigo nodularis: a reappraisal.
Liang Y; Marcusson JA; Jacobi HH; Haak-Frendscho M; Johansson O
J Cutan Pathol; 1998 Apr; 25(4):189-98. PubMed ID: 9609137
[TBL] [Abstract][Full Text] [Related]
12. Eosinophil cationic protein- and eosinophil-derived neurotoxin/eosinophil protein X-immunoreactive eosinophils in prurigo nodularis.
Johansson O; Liang Y; Marcusson JA; Reimert CM
Arch Dermatol Res; 2000 Aug; 292(8):371-8. PubMed ID: 10994770
[TBL] [Abstract][Full Text] [Related]
13. Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis.
Haas S; Capellino S; Phan NQ; Böhm M; Luger TA; Straub RH; Ständer S
J Dermatol Sci; 2010 Jun; 58(3):193-7. PubMed ID: 20417061
[TBL] [Abstract][Full Text] [Related]
14. CGRP-immunoreactive nerves in prurigo nodularis--an exploration of neurogenic inflammation.
Liang Y; Jacobi HH; Reimert CM; Haak-Frendscho M; Marcusson JA; Johansson O
J Cutan Pathol; 2000 Aug; 27(7):359-66. PubMed ID: 10917163
[TBL] [Abstract][Full Text] [Related]
15. Aberrant Expression of Histamine-independent Pruritogenic Mediators in Keratinocytes may be Involved in the Pathogenesis of Prurigo Nodularis.
Zhong W; Wu X; Zhang W; Zhang J; Chen X; Chen S; Huang H; Yang Y; Yu B; Dou X
Acta Derm Venereol; 2019 May; 99(6):579-586. PubMed ID: 30809683
[TBL] [Abstract][Full Text] [Related]
16. The pathogenesis of Prurigo nodularis--'Super-Itch' in exploration.
Zeidler C; Ständer S
Eur J Pain; 2016 Jan; 20(1):37-40. PubMed ID: 26416433
[TBL] [Abstract][Full Text] [Related]
17. Langerhans cells in prurigo nodularis investigated by HLA-DR and S-100 immunofluorescence double staining.
Johansson O; Liang Y; Heilborn JD; Marcusson JA
J Dermatol Sci; 1998 May; 17(1):24-32. PubMed ID: 9651825
[TBL] [Abstract][Full Text] [Related]
18. Antipruritic effect of cyclosporine microemulsion in prurigo nodularis: results of a case series.
Siepmann D; Luger TA; Ständer S
J Dtsch Dermatol Ges; 2008 Nov; 6(11):941-6. PubMed ID: 18445069
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of the Skin-Liver Axis in Prurigo Nodularis: An Integrated Genomic, Transcriptomic, and Population-Based Analysis.
Marani M; Madan V; Le TK; Deng J; Lee KK; Ma EZ; Kwatra SG
Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397136
[TBL] [Abstract][Full Text] [Related]
20. Reduced intraepidermal nerve fibre density in lesional and nonlesional prurigo nodularis skin as a potential sign of subclinical cutaneous neuropathy.
Schuhknecht B; Marziniak M; Wissel A; Phan NQ; Pappai D; Dangelmaier J; Metze D; Ständer S
Br J Dermatol; 2011 Jul; 165(1):85-91. PubMed ID: 21410670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
